EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, ProMIS Neurosciences's enterprise value is $7.60 Mil.
ProMIS Neurosciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil. Therefore, ProMIS Neurosciences's EV-to-Revenue for today is .
The historical rank and industry rank for ProMIS Neurosciences's EV-to-Revenue or its related term are showing as below:
During the past 13 years, the highest EV-to-Revenue of ProMIS Neurosciences was 11010.34. The lowest was -424.89. And the median was 2881.34.
PMN's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7 * Ranked among companies with meaningful EV-to-Revenue only.
ProMIS Neurosciences EV-to-Revenue Historical Data
The historical data trend for ProMIS Neurosciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ProMIS Neurosciences's EV-to-Revenue
For the Biotechnology subindustry, ProMIS Neurosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ProMIS Neurosciences's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ProMIS Neurosciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where ProMIS Neurosciences's EV-to-Revenue falls into.
ProMIS Neurosciences's current Enterprise Value is $7.60 Mil.
ProMIS Neurosciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ProMIS Neurosciences's share price for today is $0.575.
ProMIS Neurosciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ProMIS Neurosciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of ProMIS Neurosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PMN has been successfully added to your 